Li-Ting Kao

28PUBLICATIONS

38CO-AUTHORS

Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epidemiological modellingTraditional Chinese medicine and treatmentsCell physiology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (28)

Sort by Publication Date:

|May 06, 2026

Survival, Toxicity, and Economic Outcomes of Osimertinib Versus Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer.

|Dec 09, 2025

Osimertinib Versus First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Metastatic EGFR-Mutant Non-Small Cell Lung Cancer: A Target Trial Emulation Study of Real-World Survival and Safety Outcomes.

Ren-Hua Ye, Hong-Jie Jhou, Hsin-Yu Chen

|Nov 17, 2025

Healthcare utilization in cancer patients treated with immune checkpoint inhibitors: a population-based study of all patients and 1-year survivors.

Chia-Lu Hsu, Li-Fan Hsu, Sheng-Yin To

|Oct 09, 2025

Sodium-Glucose Cotransporter 2 Inhibitors and Lower Risk of Depression in Population with Type 2 Diabetes Mellitus: A Population-Based Active Comparator, New-User Design.

Ming-Jyun Kao, Ying-Chih Huang, Yu-Chieh Huang

|Sep 19, 2025

Association Between Non-Benzodiazepine Hypnotics and Tinnitus: A Nationwide Cohort Study in Taiwan.

Jen-Tin Lee, Hui-Wen Yang, Cheng-Ping Yu

|Jun 24, 2025

Paradigm Shift in the Treatment of Chronic Obstructive Pulmonary Disease Improves Patient Outcomes.

Yi-Jen Huang, Kwua-Yun Wang, Wu-Chien Chien

Pageof 5

Frequent Collaborators

Sheng-Yin To

Hui-Wen Yang

Po-Huang Chen

Hong-Jie Jhou

Chih-Hung Wang

Cho-Hao Lee

Yi-Jen Huang

Chi-Hsiang Chung

Wu-Chien Chien

Ching-Liang Ho

Frequent Collaborators

Sheng-Yin To

Hui-Wen Yang

Po-Huang Chen

Hong-Jie Jhou